Coming off the annual Oncology Clinical Pathways Congress meeting in Boston after 2 years of a virtual meeting, Winston Wong, PharmD, reflects on the past, present, and future of clinical pathways.
Coming off the annual Oncology Clinical Pathways Congress meeting in Boston after 2 years of a virtual meeting, Winston Wong, PharmD, reflects on the past, present, and future of clinical pathways.
ACCC discusses the Just ASK training program, which encourages research teams to critically assess their practices and brainstorm improvements or additions that they can make to address systemic barriers and advance health equity.
ACCC discusses the Just ASK training program, which encourages research teams to critically assess their practices and brainstorm improvements or additions that they can make to address systemic barriers and advance health equity.
Lili Brillstein, MPH, provides tips and strategies on how to answer the question, “How do you effectively engage with payers to build models for specialty care?”
Lili Brillstein, MPH, provides tips and strategies on how to answer the question, “How do you effectively engage with payers to build models for specialty care?”
The authors discuss the need for a systematic and transparent process for developing and evaluating decision support tools as it relates to their ability to address nonmedical concerns and impact, as well as patient preferences.
The authors discuss the need for a systematic and transparent process for developing and evaluating decision support tools as it relates to their ability to address nonmedical concerns and impact, as well as patient preferences.
The authors evaluate key quality considerations related to the use of telehealth in oncology in the context of the National Committee for Quality Assurance and the National Quality Forum's recommendations and discuss strategies to enhance...
The authors evaluate key quality considerations related to the use of telehealth in oncology in the context of the National Committee for Quality Assurance and the National Quality Forum's recommendations and discuss strategies to enhance...
The authors present a study that aimed to investigate the real-world use of a virtual platform, Amyloidosis Appointment Companion, in improving communication between patients with amyloidosis and their providers.
The authors present a study that aimed to investigate the real-world use of a virtual platform, Amyloidosis Appointment Companion, in improving communication between patients with amyloidosis and their providers.
A roundup of presentations from the official annual conference of the Journal of Clinical Pathways, the Oncology Clinical Pathways Congress. This congress spotlights the use and continued expansion of clinical pathways and their effect on...
A roundup of presentations from the official annual conference of the Journal of Clinical Pathways, the Oncology Clinical Pathways Congress. This congress spotlights the use and continued expansion of clinical pathways and their effect on...
Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.
Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.
This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.
This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.
In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...
In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...
This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...
This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...
In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.
In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.
Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.
Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.
In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.
In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.
NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.